OncoVista Innovative Therapies (OncoVista Innovative Therapies) Total Liabilities : $6.65 Mil (As of Sep. 2015)

View and export this data going back to 2005. Start your Free Trial

What is OncoVista Innovative Therapies Total Liabilities?

OncoVista Innovative Therapies's Total Liabilities for the quarter that ended in Sep. 2015 was $6.65 Mil.

OncoVista Innovative Therapies's quarterly Total Liabilities increased from Mar. 2015 ($6.00 Mil) to Jun. 2015 ($7.07 Mil) but then declined from Jun. 2015 ($7.07 Mil) to Sep. 2015 ($6.65 Mil).

OncoVista Innovative Therapies's annual Total Liabilities increased from Dec. 2012 ($2.25 Mil) to Dec. 2013 ($3.22 Mil) and increased from Dec. 2013 ($3.22 Mil) to Dec. 2014 ($5.68 Mil).

OncoVista Innovative Therapies Total Liabilities Historical Data

The historical data trend for OncoVista Innovative Therapies's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoVista Innovative Therapies Total Liabilities Chart

OncoVista Innovative Therapies Annual Data

Trend

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Total Liabilities

Get a 7-Day Free Trial

1.89

2.31

2.25

3.22

5.68

OncoVista Innovative Therapies Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Total Liabilities	Get a 7-Day Free Trial															4.21	5.68	6.00	7.07	6.65

OncoVista Innovative Therapies Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

OncoVista Innovative Therapies's Total Liabilities for the fiscal year that ended in Dec. 2014 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	4.976	+	(0	+	0.7
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	5.68

Total Liabilities	=	Total Assets (A: Dec. 2014 )	-	Total Equity (A: Dec. 2014 )
	=	0.013	-	-5.663
	=	5.68

OncoVista Innovative Therapies's Total Liabilities for the quarter that ended in Sep. 2015 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	5.951	+	(0	+	0.7
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	6.65

Total Liabilities	=	Total Assets (Q: Sep. 2015 )	-	Total Equity (Q: Sep. 2015 )
	=	0.061	-	-6.59
	=	6.65

OncoVista Innovative Therapies Total Liabilities Related Terms

Thank you for viewing the detailed overview of OncoVista Innovative Therapies's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoVista Innovative Therapies (OncoVista Innovative Therapies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoVista Innovative Therapies Inc (OTCPK:OVIT) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245

Website

http://www.oncovista.com

OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.

Executives

Alexander Ruckdaeschel	director	123 EAST 83RD STREET, APT 3-B, NEW YORK NY 10028
Paul A Mieyal	director	C/O WEXFORD CAPITAL LP, 411 WEST PUTNAM AVE, SUITE 125, GREENWICH CT 06830
Charles E Davidson	10 percent owner	C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602, WEST PALM BEACH FL 33401
Wexford Capital Lp	10 percent owner	777 WEST PUTNAM AVENUE, 1ST FLOOR, GREENWICH CT 06830
Joseph Jacobs	10 percent owner	C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602 EAST, WEST PALM BEACH FL 33401
Wexford Spectrum Trading Ltd	10 percent owner	411 WEST PUTNAM AVENUE, SUITE 125, GREENWICH CT 06830

OncoVista Innovative Therapies (OncoVista Innovative Therapies) Headlines

No Headlines